Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE: 002603)
China
· Delayed Price · Currency is CNY
17.80
+0.08 (0.45%)
Nov 15, 2024, 10:07 AM CST
Shijiazhuang Yiling Pharmaceutical Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
Net Income | 148.47 | 1,352 | 2,363 | 1,344 | 1,219 | 606.5 | Upgrade
|
Depreciation & Amortization | 547.13 | 547.13 | 451.47 | 362.93 | 268.16 | 259.69 | Upgrade
|
Other Amortization | 4.11 | 4.11 | 0.66 | 4.85 | 6.78 | 4.01 | Upgrade
|
Loss (Gain) From Sale of Assets | 0.82 | 0.82 | 3.11 | 2.52 | -0.14 | 0.24 | Upgrade
|
Asset Writedown & Restructuring Costs | 11.15 | 11.15 | 95.62 | 10.76 | 53.12 | 1.25 | Upgrade
|
Loss (Gain) From Sale of Investments | -78.08 | -78.08 | -11.5 | -4.42 | -29.6 | -30.12 | Upgrade
|
Provision & Write-off of Bad Debts | 22.21 | 22.21 | 16.62 | 36.93 | 5.04 | 4.06 | Upgrade
|
Other Operating Activities | 1,439 | 56.82 | 44.94 | 51.24 | 21.63 | -1.73 | Upgrade
|
Change in Accounts Receivable | -700.49 | -700.49 | -831.66 | -1,280 | -668.73 | -800.37 | Upgrade
|
Change in Inventory | -459.67 | -459.67 | -348.01 | -104.74 | -364.91 | -40.85 | Upgrade
|
Change in Accounts Payable | -722.76 | -722.76 | 1,886 | 55.15 | 1,126 | -6.41 | Upgrade
|
Change in Other Net Operating Assets | 17.35 | 17.35 | -22.82 | 29.75 | 17.67 | 81.52 | Upgrade
|
Operating Cash Flow | 333.46 | 155.46 | 3,488 | 528.69 | 1,586 | 68.93 | Upgrade
|
Operating Cash Flow Growth | -86.15% | -95.54% | 559.69% | -66.67% | 2201.29% | -4.76% | Upgrade
|
Capital Expenditures | -336.42 | -310.83 | -213.98 | -673.56 | -1,145 | -454.43 | Upgrade
|
Sale of Property, Plant & Equipment | 0.35 | 0.97 | 0.35 | 1.2 | 0.3 | 0.25 | Upgrade
|
Cash Acquisitions | -47.41 | -676.29 | - | - | - | - | Upgrade
|
Divestitures | - | - | - | - | - | 7.12 | Upgrade
|
Investment in Securities | 565.5 | 49.1 | -1,789 | 159.33 | 78.94 | 457.59 | Upgrade
|
Other Investing Activities | 29.93 | 37.83 | 7.66 | 6.28 | 25.34 | 26.59 | Upgrade
|
Investing Cash Flow | 211.95 | -899.22 | -1,995 | -506.76 | -1,040 | 37.12 | Upgrade
|
Short-Term Debt Issued | - | 500 | - | - | - | 50 | Upgrade
|
Long-Term Debt Issued | - | 1,200 | 1,850 | 2,400 | 489.98 | - | Upgrade
|
Total Debt Issued | 1,370 | 1,700 | 1,850 | 2,400 | 489.98 | 50 | Upgrade
|
Short-Term Debt Repaid | - | -393 | - | - | - | - | Upgrade
|
Long-Term Debt Repaid | - | -654.82 | -2,204 | -1,483 | -269.98 | - | Upgrade
|
Total Debt Repaid | -1,601 | -1,048 | -2,204 | -1,483 | -269.98 | - | Upgrade
|
Net Debt Issued (Repaid) | -230.79 | 652.18 | -354.3 | 916.81 | 220 | 50 | Upgrade
|
Issuance of Common Stock | - | - | - | - | - | 0.17 | Upgrade
|
Repurchase of Common Stock | - | - | - | - | - | -99.96 | Upgrade
|
Common Dividends Paid | -717.08 | -872.77 | -282.7 | -1,220 | -244.1 | -119.8 | Upgrade
|
Other Financing Activities | 272.21 | - | - | 1.18 | 0.84 | - | Upgrade
|
Financing Cash Flow | -675.66 | -220.59 | -637 | -302.15 | -23.26 | -169.59 | Upgrade
|
Foreign Exchange Rate Adjustments | -0.12 | 0.33 | 1.25 | -0.48 | -1.95 | -0.64 | Upgrade
|
Net Cash Flow | -130.36 | -964.03 | 857.18 | -280.69 | 520.76 | -64.18 | Upgrade
|
Free Cash Flow | -2.96 | -155.38 | 3,274 | -144.87 | 441.39 | -385.5 | Upgrade
|
Free Cash Flow Margin | -0.04% | -1.51% | 26.12% | -1.43% | 5.03% | -6.62% | Upgrade
|
Free Cash Flow Per Share | -0.00 | -0.09 | 1.96 | -0.09 | 0.26 | -0.23 | Upgrade
|
Cash Income Tax Paid | 689.37 | 1,324 | 1,322 | 1,174 | 1,162 | 727.9 | Upgrade
|
Levered Free Cash Flow | 379.55 | 104.32 | 3,670 | 251.91 | 1,364 | -420.06 | Upgrade
|
Unlevered Free Cash Flow | 405.48 | 128.63 | 3,691 | 273.14 | 1,371 | -420.01 | Upgrade
|
Change in Net Working Capital | -96.34 | 1,120 | -1,669 | 370.29 | -1,349 | 636.06 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.